Cortesi E - Search Results

1

Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.

Cortesi E, Caponnetto S, Masi G, Urbano F, Mezi S, Gelibter A, Pelle G, Filippi L, Cianni R. Cortesi E, et al. Clin Colorectal Cancer. 2020 Dec;19(4):e272-e276. doi: 10.1016/j.clcc.2020.06.008. Epub 2020 Jun 30. Clin Colorectal Cancer. 2020. PMID: 32768271

2

Advanced colorectal cancer: impact of chemotherapy on survival.

Cortesi E, Padovani A, Aloe A, Picece V, Pellegrini P, Pellegrini A. Cortesi E, et al. J Surg Oncol Suppl. 1991;2:112-5. doi: 10.1002/jso.2930480524. J Surg Oncol Suppl. 1991. PMID: 1892519 Review. No abstract available.

3

Bolus vs. continuous hepatic arterial infusion of cisplatin plus intravenous 5-fluorouracil chemotherapy for unresectable colorectal metastases.

Cortesi E, Capussotti L, Di Tora P, Mannella E, Casaldi V, Civalleri D, Morandi GB, Da Pian PP, Padovani A, Callopoli A, et al. Cortesi E, et al. Dis Colon Rectum. 1994 Feb;37(2 Suppl):S138-43. doi: 10.1007/BF02048447. Dis Colon Rectum. 1994. PMID: 8313786 Clinical Trial.

4

Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: a phase I-II trial.

Nelli F, Naso G, De Pasquale Ceratti A, Saltarelli R, Dauria G, Lugini A, Ferraldeschi R, Picone V, Moscetti L, Cortesi E. Nelli F, et al. Among authors: cortesi e. J Chemother. 2004 Aug;16(4):392-9. doi: 10.1179/joc.2004.16.4.392. J Chemother. 2004. PMID: 15332716 Clinical Trial.

5

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.

Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G; Gruppo Oncologico Nord Ovest. Falcone A, et al. Among authors: cortesi e. J Clin Oncol. 2007 May 1;25(13):1670-6. doi: 10.1200/JCO.2006.09.0928. J Clin Oncol. 2007. PMID: 17470860 Clinical Trial.

6

Induction therapy with paclitaxel and carboplatin followed by hyperfractionated radiotherapy plus weekly concurrent chemotherapy and subsequent consolidation therapy in unresectable locally advanced non-small-cell lung cancer.

Cortesi E, Moscetti L, Nelli F, De Marinis F, De Paula U, Bangrazi C, Migliorino MR, Donato V. Cortesi E, et al. Tumori. 2007 Mar-Apr;93(2):133-7. doi: 10.1177/030089160709300204. Tumori. 2007. PMID: 17557558 Clinical Trial.

7

A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicities.

Gamucci T, Nelli F, Cianci G, Grassi G, Moscetti L, Sperduti I, Zeuli M, Cortesi E, D'Auria G, Pollera CF. Gamucci T, et al. Among authors: cortesi e. Clin Colorectal Cancer. 2008 Jul;7(4):273-9. doi: 10.3816/CCC.2008.n.035. Clin Colorectal Cancer. 2008. PMID: 18650196 Clinical Trial.

8

Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases.

Cianni R, Urigo C, Notarianni E, Saltarelli A, Salvatori R, Pasqualini V, Dornbusch T, Cortesi E. Cianni R, et al. Among authors: cortesi e. Cardiovasc Intervent Radiol. 2009 Nov;32(6):1179-86. doi: 10.1007/s00270-009-9658-8. Epub 2009 Aug 13. Cardiovasc Intervent Radiol. 2009. PMID: 19680720

9

Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases.

Cianni R, Urigo C, Notarianni E, Saltarelli A, D'Agostini A, Iozzino M, Dornbusch T, Cortesi E. Cianni R, et al. Among authors: cortesi e. Radiol Med. 2010 Jun;115(4):619-33. doi: 10.1007/s11547-010-0496-1. Epub 2010 Jan 20. Radiol Med. 2010. PMID: 20091135 English, Italian.

10

Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.

Loupakis F, Masi G, Fornaro L, Vasile E, Allegrini G, Fontana E, Granetto C, Salvatore L, Mentuccia L, Andreuccetti M, Cortesi E, Merlano M, Cascinu S, Falcone A. Loupakis F, et al. Among authors: cortesi e. Cancer Chemother Pharmacol. 2010 Aug;66(3):559-66. doi: 10.1007/s00280-009-1196-1. Epub 2010 Mar 17. Cancer Chemother Pharmacol. 2010. PMID: 20237927 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters